Carbinoxamine / methscopolamine / pseudoephedrine Pregnancy and Breastfeeding Warnings
Brand names: Nacon, Pannaz, Pannaz S, Pseudox M
Carbinoxamine / methscopolamine / pseudoephedrine Pregnancy Warnings
Carbinoxamine/methscopolamine/pseudoephedrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. Carbinoxamine/methscopolamine/pseudoephedrine is only recommended for use during pregnancy when benefit outweighs risks.
Carbinoxamine / methscopolamine / pseudoephedrine Breastfeeding Warnings
There are no data on the excretion of carbinoxamine/methscopolamine/pseudoephedrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- (2004) "Product Information. Pannaz (carbinoxamine/methscopolamine/pseudoephedrine)." Alfasigma USA Inc (formerly Pamlab LLC)
References for breastfeeding information
- (2004) "Product Information. Pannaz (carbinoxamine/methscopolamine/pseudoephedrine)." Alfasigma USA Inc (formerly Pamlab LLC)
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.